Resveratrol and Gliomas: Where are we standing?

سال انتشار: 1399
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 355

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ICIBS01_284

تاریخ نمایه سازی: 2 آذر 1399

چکیده مقاله:

Gliomas are well-known brain and spinal cord tumors. These tumors are a heterogeneous group of brain tumors with different biological and clinical features. Surgery and chemotherapy are known as current therapeutic platform in the treatment of various types of gliomas. Despite different advances in the therapeutic approaches in the treatment of gliomas, several limitations are associated with them. Hence, finding and developing new therapeutic option are necessary. Plans medicine are new horizons which could be employed as new anti-cancer agents. Resveratrol is well known natural compounds that can be used as therapeutic agent alone or in combination with other chemotherapy drugs. Resveratrol shows pharmacology activities such as anti-cancer, anti-aging, anti-inflammatory, chemotherapeutic, cardio protective, and neuroprotective action. Several studies indicated that resveratrol exerts therapeutic effects on glioma cells. Given that this natural compound exerts its therapeutic impacts on gliomas via targeting different physiological and pathological events such as apoptosis, growth, angiogenesis, and metastasis. Herein, we summarized the anti-gliomas effects of resveratrol.

نویسندگان

Maryam Fallah

Student Research Committee, Kashan University of Medical Sciences, Kashan, I.R. Iran

Hamed Mirzaei

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran